Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Olmesartan: Reduction of Blood Pressure in the Treatment of Patients Suffering From Mild to Moderate Essential Hypertension

NCT00185172 is registered in ClinicalTrials.gov with Sankyo Pharma Gmbh as lead sponsor.

NCT NCT00185172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Olmesartan: Reduction of Blood Pressure in the Treatment of Patients Suffering From Mild to Moderate Essential Hypertension
Lead sponsor
Sankyo Pharma Gmbh
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2002
Completion date
June 30, 2005
Enrollment
2,333 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension